Mereo BioPharma Company
Kinase inhibitors and other in pipeline for various, inclusing COPD. Mission is to provide new therapies to patients with chronically debilitating and life limiting rare diseases that have few, if any, other treatment options.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
2015
Employees Number:
11-50
Funding Status:
IPO
Estimated Revenue:
$100M to $500M
Register and Claim Ownership